Ask AI

Evaluating the Role of Biosimilars in the Management of Rheumatologic Conditions

In these downloadable slidesets our expert faculty members Stanley B. Cohen MD Jonathan Kay MD and Kenneth G. Saag MD MSc explore the expanding role of biosimilars in the management of rheumatologic conditions.

Share

Supporters

Supported by independent educational grants from

Boehringer Ingelheim

Sandoz